Colin Bier

Managing & Scientific Director, ABA BioResearch; Fifteen years of experience in CRO (pharmacology and toxicology); twenty years bioregulatory consulting; Faculty of Medicine, McGill University; Board member, Mount Sinai Hospital Corporation; Special Advisor, Centre for Translational Research in Cancer R&D, Jewish General Hospital (McGill University); Senior advisor at NGN Capital. Several board seats, public & private and Scientific Advisory Boards.